Abnormalities of uterine cervix in women with inflammatory bowel disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

465

HTML

3162

Tables (1-6)

278

Sum=3905

Oct 14, 2006 (publication date) through Feb 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 14, 2006; 12(38): 6167-6171
Published online Oct 14, 2006. doi: 10.3748/wjg.v12.i38.6167

Table 6 Incidence of abnormal pap results in 116 IBD patients after treatment

Pap results	Normal papn (%)	Abnormal papn (%)	Total(n)	P
Corticosteroids	49 (80)	12 (20)	61	0.747
No corticosteroids	43 (83)	9 (17)	52
5-ASA¹	88 (82)	20 (19)	108	0.934
No 5-ASA¹	4 (80)	1 (20)	5
Immunosuppressives² and Anti-TNF α³	54 (79)	14 (21)	68	0.381
No immunosuppressives² and no Anti-TNF α³	42 (86)	7 (14)	49

¹5-aminosalicylates (sulfasalazine, mesalamine, olsalazine, etc);

²Monoclonal antibody to Tumor Necrosis Factor α (infliximab);

³6-mp and/or azathioprine.

Citation: Bhatia J, Bratcher J, Korelitz B, Vakher K, Mannor S, Shevchuk M, Panagopoulos G, Ofer A, Tamas E, Kotsali P, Vele O. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol 2006; 12(38): 6167-6171
URL: https://www.wjgnet.com/1007-9327/full/v12/i38/6167.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i38.6167